Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin...

Details Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin... Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin...

A - Human Necessities

61

K

A61K 31/593 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2540051

This invention provides pharmaceutical uses for 2-methylene-1 9-nor~ 20(S)- 1a,25-dihydroxyvitamin D3. Administration of this compound increases the life expectancy of human beings, especially elderly human beings. In particular, it increases the survival rate of females lacking estrogen, especially post~ menopausal females, and reduces mortality resulting from sponta neous development of malignant tumors in both males and females.

L'invention concerne des utilisations pharmaceutiques de la 2-méthylène-19-nor-20(S)-1 alpha ,25-dihydroxyvitamine D3. L'administration de ce composé accroît l'espérance de vie d'êtres humains, en particulier de personnes âgées et accroît plus particulièrement le taux de survie des femmes manquant d'oestrogène, spécialement en post-ménopause, et réduit la mortalité résultant du développement spontané de tumeurs malignes, ceci à la fois chez les hommes et les femmes.

Affiliated with

Also associated with

Rating

Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2082012